Education
About Us
Working with TipRanks
Follow Us
Cory Jubinville, PhD Profile - LifeSci Capital Analyst
165 Followers
Cory Jubinville, PhD LifeSci Capital
Wall Street Analyst
Success Rate
68 out of 118 ratings made a profit
Average Return
+26.20%
Average return per rating
Time Frame
Compare to
Copying Cory Jubinville, PhD's trades since 2024 and holding each position for 1 Year would result in 57.63% of your transactions generating a profit, with an average return of 26.2% per rating.
Stock Rating Distribution
98.74% Buy
1.26% Hold
0.00% Sell
Distribution of Cory Jubinville, PhD's ratings
Additional Information
Main Sector:General
Geo Coverage:
Best Rating
The most profitable rating made by Cory Jubinville, PhD
Cory Jubinville, PhD's Stock Coverage
CymaBay Therapeutics
Feb 13, 2024
Hold
Downgraded
―
2Ratings
+35.40%
Verve Therapeutics
Jun 17, 2025
Hold
Downgraded
$12.00
(7.82% Upside)
14Ratings
+33.96%
Liquidia Technologies
Nov 03, 2025
Buy
Reiterated
$67.00
(96.83% Upside)
22Ratings
+112.08%
Larimar Therapeutics
Nov 05, 2025
Buy
Reiterated
$22.00
(445.91% Upside)
21Ratings
-4.74%
Tarsus Pharmaceuticals
Nov 05, 2025
Buy
Reiterated
$84.00
(5.59% Upside)
14Ratings
+61.11%
Rocket Pharmaceuticals
Nov 07, 2025
Buy
Reiterated
$9.00
(167.86% Upside)
17Ratings
-48.31%
Crinetics Pharmaceuticals
Nov 07, 2025
Buy
Reiterated
$93.00
(94.15% Upside)
29Ratings
+37.63%
Mereo Biopharma Group Plc
Nov 11, 2025
Buy
Reiterated
$9.00
(312.84% Upside)
12Ratings
-12.86%
Tenaya Therapeutics
Nov 15, 2025
Buy
Reiterated
$3.00
(112.77% Upside)
22Ratings
+32.05%
Tectonic Therapeutic
Nov 18, 2025
Buy
Reiterated
$88.00
(346.70% Upside)
5Ratings
-3.15%
List of latest recommendations made by Cory Jubinville, PhD. Click to expand and see Cory Jubinville, PhD's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Cory Jubinville, PhD activity FAQ
What is the performance of Cory Jubinville, PhD's recommendations?
The percentage of profitable recommendations made by Cory Jubinville, PhD is 58%, and the average return per transaction is 26.20%.
What stocks does Cory Jubinville, PhD cover?
What was Cory Jubinville, PhD's most profitable rating?
Cory Jubinville, PhD’s most profitable ratings was a buy on TNYA stock on May 09, 2025 - Today. The return on the trade was +236.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here